A Win For Viking Therapeutics, Inc.

Tue, Feb 27, 2024 at 07:12 PM
A Win For Viking Therapeutics, Inc.

Viking Therapeutics, Inc. (VKTX:NASDAQ) soared at $85.05, a gain of 121%. On Tue, Feb 27, 2024, VKTX:NASDAQ hit a New 2-Week High of $85.05. The stock got featured on our News Catalysts scanner on Tue, Feb 27, 2024 at 05:51 PM in the 'PUBLIC OFFERING' category. From Tue, Feb 13, 2024, the stock recorded 66.67% Up Days and 70.00% Green Days

About Viking Therapeutics, Inc. (VKTX:NASDAQ)

Viking Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company develops therapies for metabolic and endocrine disorders. It includes portfolio of five drug candidates in clinical trials or preclinical studies.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.